Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-19T01:24:16.279Z Has data issue: false hasContentIssue false
  • English
  • Français

Priapism and Psychotropic Medication

Published online by Cambridge University Press:  29 January 2018

John Kogeorgos  and
Chandu de Alwis
John Kogeorgos*
Affiliation:
Horton Hospital, Long Grove Road, Epsom, Surrey KT19 8PZ and Honorary Consultant, St Mary's Hospital, London
Chandu de Alwis
Affiliation:
Horton Hospital, Epsom
*
∗Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

Priapism is a rare but serious adverse effect of psychotropic drugs resulting from their peripheral alpha-adrenoreceptor blocking action. Two patients developed this during treatment with oral phenothiazines: one was treated surgically with a venous shunt, and the second case resolved after intracavernosal injection of an alpha-adrenoreceptor stimulating drug.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 149 , Issue 2 , August 1986 , pp. 241 - 243
Copyright
Copyright © 1986 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Barnes, T. R. E. (1984) Drugs and sexual dysfunction In Current Themes in Psychiatry, 3, (eds Gaind, R. N. et al). London: Macmillan.Google Scholar
Bloom, S. R. & Edwards, A. V. (1980) Vasoactive intestinal peptides in relation to atropine resistant vasodilation in the submaxillary gland of the cat. Journal of Physiology, 300, 41–53.CrossRefGoogle ScholarPubMed
Brindley, G. S. (1983) Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence. British Journal of Psychiatry, 143, 332–337.Google Scholar
Brindley, G. S. (1984) New treatment for priapism. The Lancet, i, 220–221.CrossRefGoogle Scholar
Dawson-Butterworth, K. (1969) Idiopathic priapism associated with schizophrenia. British Journal of Clinical Practice, 23, 125–126.Google ScholarPubMed
Lawrence, J. M., Stewart, T. & Frankel, F. H. (1984) Alpha blockade and priapism. American Journal of Psychiatry, 141, 825.Google ScholarPubMed
Meiraz, D. & Fishelovitch, J. (1969) Priapism and Largactil medication. Israel Journal of Medical Sciences, 5, 1254–1255.Google Scholar
Mitchell, J. E. & Popkin, M. (1982) Antipsychotic drug therapy and sexual dysfunction in men. American Journal of Psychiatry, 139, 633–637.Google ScholarPubMed
Polak, J. M., Mina, S., Gu, J. & Bloom, S. R. (1981) Vipergic nerves in the penis. The Lancet, ii, 217–219.CrossRefGoogle Scholar
Pryor, J. P. (1982) Priapism. Practitioner, 226, 1873–1879.Google ScholarPubMed
Scher, M., Krieger, J. N. & Juergens, S. (1983) Trazodone and priapism. American Journal of Psychiatry, 140, 1362–1363.Google ScholarPubMed
Stanners, A. & Colin-Jones, D. (1984) Metaraminol for priapism. The Lancet, i, 978.CrossRefGoogle Scholar
Wagner, G., Willis, E. A., Bro-Rasmussen, F. & Nielsen, M. H. (1982) New theory on the mechanism of erection involving hitherto undescribed vessels. The Lancet, i, 416–418.Google Scholar
Wasmer, J. M., Carrion, H. M., Mekkas, G. & Politano, V. A. (1981) Evaluation and treatment of priapism. Journal of Urology, 125, 204–207.CrossRefGoogle ScholarPubMed
Winter, C. W. (1981) Priapism. Journal of Urology, 125, 212.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.